Published in Cell Mol Immunol on April 08, 2013
Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest (2013) 1.12
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma. Cell Mol Immunol (2014) 1.04
Zfra activates memory Hyal-2+ CD3- CD19- spleen cells to block cancer growth, stemness, and metastasis in vivo. Oncotarget (2015) 0.89
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. World J Gastroenterol (2015) 0.87
PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells. Oncotarget (2016) 0.84
Influenza vaccine induces intracellular immune memory of human NK cells. PLoS One (2015) 0.82
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget (2016) 0.79
Frontiers in natural killer cell immunology. Cell Mol Immunol (2013) 0.76
NK cells and virus-related cancers. Crit Rev Oncog (2014) 0.75
Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors. Immunotargets Ther (2015) 0.75
The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells. J Exp Med (2016) 0.75
The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk. J Immunol Res (2016) 0.75
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 34.47
Preferential localization of effector memory cells in nonlymphoid tissue. Science (2001) 14.22
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Immunological memory and protective immunity: understanding their relation. Science (1996) 10.02
Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68
Adaptive immune features of natural killer cells. Nature (2009) 8.46
A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 8.42
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Visualizing the generation of memory CD4 T cells in the whole body. Nature (2001) 7.07
Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73
T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol (2006) 6.23
Cytokine control of memory T-cell development and survival. Nat Rev Immunol (2003) 5.99
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol (2006) 4.48
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34
In vivo developmental stages in murine natural killer cell maturation. Nat Immunol (2002) 4.25
Lifetime of plasma cells in the bone marrow. Nature (1997) 3.99
The dynamic life of natural killer cells. Annu Rev Immunol (2004) 3.96
Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74
Organization of immunological memory by bone marrow stroma. Nat Rev Immunol (2010) 3.57
Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity (1995) 3.51
Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity (2005) 3.39
Maturation of mouse NK cells is a 4-stage developmental program. Blood (2009) 3.31
Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol (2006) 3.31
Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol (2004) 3.14
Liver: An organ with predominant innate immunity. Hepatology (2008) 3.13
Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol (2012) 3.05
Memory B-cell persistence is independent of persisting immunizing antigen. Nature (2000) 2.90
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89
Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity (2009) 2.73
Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol (2001) 2.71
Cytokine activation induces human memory-like NK cells. Blood (2012) 2.58
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (2012) 2.47
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Survival of long-lived plasma cells is independent of antigen. Int Immunol (1998) 2.45
NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol (2007) 2.26
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood (2003) 2.20
How alpha beta T cells deal with induced TCR alpha ablation. Proc Natl Acad Sci U S A (2001) 2.19
Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest (2013) 2.06
Living in the liver: hepatic infections. Nat Rev Immunol (2012) 2.03
beta-Estradiol reduces natural killer cells in mice. J Immunol (1978) 2.02
Presence of hematopoietic stem cells in the adult liver. Nat Med (1996) 2.00
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol (2012) 1.98
Natural killer cell memory. Nat Immunol (2011) 1.96
Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med (2012) 1.89
The bone marrow: a nest for migratory memory T cells. Trends Immunol (2005) 1.88
A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers. Immunity (2011) 1.84
Identification of the earliest NK-cell precursor in the mouse BM. Blood (2011) 1.54
The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med (1979) 1.51
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood (2011) 1.45
Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration. J Immunol (1979) 1.44
Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. J Immunol (1972) 1.37
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog (2011) 1.23
E4BP4: an unexpected player in the immune response. Trends Immunol (2011) 1.19
Organization and maintenance of immunological memory by stroma niches. Eur J Immunol (2009) 1.19
Bone marrow and the control of immunity. Cell Mol Immunol (2011) 1.15
Origin of blood cells and HSC production in the embryo. Trends Immunol (2012) 1.14
TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest (2011) 1.13
A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity. Blood (2005) 1.10
Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens. Eur J Immunol (2011) 0.94
Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy. Cell Mol Immunol (2012) 0.93
Genital HSV-2 infection induces short-term NK cell memory. PLoS One (2012) 0.92
CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol (2008) 0.91
HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway. Cell Mol Immunol (2011) 0.86
Development of murine hepatic NK cells during ontogeny: comparison with spleen NK cells. Clin Dev Immunol (2011) 0.85
More things in heaven and earth: defining innate and adaptive immunity. Nat Immunol (2010) 0.84
Stimulatory lipids accumulate in the mouse liver within 30 min of contact sensitization to facilitate the activation of Naïve iNKT cells in a CD1d-dependent fashion. Scand J Immunol (2011) 0.83
Lessons learned at the intersection of immunology and neuroscience. J Clin Invest (2012) 0.82
Single line or parallel lines: NK cell differentiation driven by T-bet and Eomes. Cell Mol Immunol (2012) 0.81
The origin of IgE memory and plasma cells. Cell Mol Immunol (2012) 0.77
Liver: An organ with predominant innate immunity. Hepatology (2008) 3.13
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology (2006) 3.03
Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest (2002) 2.40
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity (2013) 2.39
NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol (2013) 2.39
Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes (2007) 2.32
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology (2003) 2.00
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97
MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest (2012) 1.86
Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem (2009) 1.85
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr Opin Immunol (2013) 1.79
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest (2016) 1.62
Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol (2005) 1.59
Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology (2004) 1.54
Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology (2007) 1.49
Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients. Rheumatol Int (2013) 1.46
Surgical strategy and management outcomes for adjacent multisegmental spinal tuberculosis: a retrospective study of forty-eight patients. Spine (Phila Pa 1976) (2014) 1.41
Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J Immunol (2007) 1.40
Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci U S A (2005) 1.40
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res (2008) 1.35
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther (2007) 1.30
Next-generation sequencing of the Chrysanthemum nankingense (Asteraceae) transcriptome permits large-scale unigene assembly and SSR marker discovery. PLoS One (2013) 1.29
NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology (2009) 1.28
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer (2007) 1.26
TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog (2012) 1.25
CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem (2009) 1.25
Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology (2010) 1.24
Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity. Cancer Res (2007) 1.24
Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun (2003) 1.21
Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes. J Exp Med (2013) 1.21
Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep (2009) 1.20
The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol (2007) 1.19
Involvement of natural killer cells in PolyI:C-induced liver injury. J Hepatol (2004) 1.17
Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer. BMC Cancer (2008) 1.15
High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages. Hepatology (2013) 1.15
Cloning and characterization of a beta-glucosidase from marine microbial metagenome with excellent glucose tolerance. J Microbiol Biotechnol (2010) 1.15
Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology (2009) 1.14
IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J Immunol (2004) 1.14
JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augment. Cancer Biol Ther (2008) 1.12
NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc Natl Acad Sci U S A (2007) 1.12
Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A (2012) 1.11
Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus. Cell Mol Immunol (2005) 1.11
Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol (2005) 1.11
Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Hum Immunol (2008) 1.10
ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol Pharm (2011) 1.09
Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat Commun (2013) 1.09
A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion. ACS Chem Biol (2014) 1.08
Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol (2011) 1.08
Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J (2011) 1.07
Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. FASEB J (2008) 1.07
Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. Cancer Lett (2008) 1.06
Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol (2006) 1.06
Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray. Mol Pharmacol (2005) 1.05
HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase. J Neurochem (2007) 1.04
Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1. J Biol Chem (2007) 1.04
Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy. Curr Med Chem (2007) 1.03
Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Cancer Immunol Immunother (2009) 1.02
Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis (2013) 1.02
STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes. Oncol Rep (2007) 1.02
Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology (2007) 1.02
Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol (2003) 1.01
Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine (2008) 1.01
NK cells in immunotolerant organs. Cell Mol Immunol (2013) 1.01
Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology (2012) 1.01
Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One (2013) 1.01
Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol (2011) 1.00
E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells. Cancer Res (2009) 1.00
IGF-1 promotes the development and cytotoxic activity of human NK cells. Nat Commun (2013) 1.00
Traditional Chinese medicine and immune regulation. Clin Rev Allergy Immunol (2013) 0.99
A novel NF-kappaB binding site controls human granzyme B gene transcription. J Immunol (2006) 0.99
Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices. Biomaterials (2004) 0.99
Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol (2006) 0.99
Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy. Haematologica (2004) 0.99
The regulatory effect of natural killer cells: do "NK-reg cells" exist? Cell Mol Immunol (2006) 0.98
Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells: differential involvement of adenosine. J Biol Chem (2002) 0.98
Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells. Int Immunopharmacol (2005) 0.98
High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells. Hepatology (2013) 0.98
Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo. Biochem Biophys Res Commun (2004) 0.98
High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol (2007) 0.98
CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology (2011) 0.98
The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. Am J Clin Nutr (2012) 0.98
Adenoviruses in lymphocytes of the human gastro-intestinal tract. PLoS One (2011) 0.98
A bacterial laccase from marine microbial metagenome exhibiting chloride tolerance and dye decolorization ability. Appl Microbiol Biotechnol (2010) 0.97
CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice. J Immunol (2008) 0.97
The University of Texas Houston Stroke Registry (UTHSR): implementation of enhanced data quality assurance procedures improves data quality. BMC Neurol (2013) 0.97
Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Hepatology (2013) 0.97
Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol (2007) 0.96
Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis (2011) 0.95
Graphene oxide exhibits broad-spectrum antimicrobial activity against bacterial phytopathogens and fungal conidia by intertwining and membrane perturbation. Nanoscale (2014) 0.95
Lung natural killer cells in mice: phenotype and response to respiratory infection. Immunology (2012) 0.95
mRNA secondary structure at start AUG codon is a key limiting factor for human protein expression in Escherichia coli. Biochem Biophys Res Commun (2006) 0.95
Partial stapled hemorrhoidopexy: a minimally invasive technique for hemorrhoids. Surg Today (2011) 0.95
Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells. J Neurooncol (2008) 0.95
TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J Neuroimmunol (2004) 0.95
Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp. PLoS One (2011) 0.95